Alex Buko

2.8k total citations · 1 hit paper
29 papers, 2.0k citations indexed

About

Alex Buko is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Alex Buko has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Cancer Research. Recurrent topics in Alex Buko's work include Microbial Natural Products and Biosynthesis (8 papers), Synthesis and Biological Activity (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Alex Buko is often cited by papers focused on Microbial Natural Products and Biosynthesis (8 papers), Synthesis and Biological Activity (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Alex Buko collaborates with scholars based in United States, United Kingdom and Germany. Alex Buko's co-authors include Jon F. Denissen, Gondi Kumar, A. David Rodrigues, Susan Goelz, Pradeep Bista, Ralf Gold, Rebecca Conrad, K. P. DAWSON, Matvey Lukashev and Stefan Wiese and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Brain.

In The Last Decade

Alex Buko

29 papers receiving 1.9k citations

Hit Papers

Fumaric acid esters exert neuroprotective effects in neur... 2011 2026 2016 2021 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Buko United States 18 832 337 323 283 257 29 2.0k
Lawrence C. Trost United States 15 1.4k 1.7× 228 0.7× 210 0.7× 92 0.3× 218 0.8× 23 2.5k
Ping Lü China 28 1.1k 1.3× 52 0.2× 451 1.4× 320 1.1× 299 1.2× 69 2.6k
Shugo Ueda Japan 26 1.4k 1.7× 99 0.3× 171 0.5× 79 0.3× 397 1.5× 67 2.8k
I. Yu. Torshin Russia 22 660 0.8× 103 0.3× 154 0.5× 213 0.8× 60 0.2× 301 1.9k
Lucy A. Hunsaker United States 31 1.3k 1.5× 264 0.8× 95 0.3× 267 0.9× 224 0.9× 51 3.3k
Stephen Jenkinson United States 30 1.2k 1.4× 57 0.2× 192 0.6× 126 0.4× 245 1.0× 98 3.2k
Richard Hajdu United States 18 1.9k 2.3× 181 0.5× 176 0.5× 377 1.3× 220 0.9× 24 2.8k
Hirotami Matsuo Japan 25 890 1.1× 82 0.2× 157 0.5× 178 0.6× 809 3.1× 49 2.4k
Xiao Ding China 28 1.2k 1.5× 63 0.2× 408 1.3× 245 0.9× 275 1.1× 118 2.7k
Sonsoles Hortelano Spain 33 1.7k 2.0× 196 0.6× 52 0.2× 352 1.2× 303 1.2× 79 3.6k

Countries citing papers authored by Alex Buko

Since Specialization
Citations

This map shows the geographic impact of Alex Buko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Buko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Buko more than expected).

Fields of papers citing papers by Alex Buko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Buko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Buko. The network helps show where Alex Buko may publish in the future.

Co-authorship network of co-authors of Alex Buko

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Buko. A scholar is included among the top collaborators of Alex Buko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Buko. Alex Buko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lerer, Elad, Alex Buko, Karin Blakolmer, et al.. (2024). Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain. Molecular Psychiatry. 29(7). 2059–2073. 15 indexed citations
3.
Jalali, Shahrzad, Jie Shi, Alex Buko, et al.. (2020). Increased glutathione utilization augments tumor cell proliferation in Waldenstrom Macroglobulinemia. Redox Biology. 36. 101657–101657. 11 indexed citations
4.
Wharton, Keith A., Catherine Quigley, Robert W. Dunstan, et al.. (2016). JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection. PLoS ONE. 11(5). e0155897–e0155897. 18 indexed citations
5.
Linker, Ralf A., De-Hyung Lee, Sarah Ryan, et al.. (2011). Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain. 134(3). 678–692. 892 indexed citations breakdown →
6.
Bowes, Scott, Dongyu Sun, Chenhui Zeng, et al.. (2006). Quality Assessment and Analysis of Biogen Idec Compound Library. SLAS DISCOVERY. 11(7). 828–835. 13 indexed citations
7.
Harlan, John E., David A. Egan, Uri S. Ladror, et al.. (2003). Driving Affinity Selection by Centrifugal Force. Assay and Drug Development Technologies. 1(4). 507–519. 6 indexed citations
9.
Shen, Jianwei & Alex Buko. (2002). Rapid identification of proteins in polyethylene glycol-containing samples using capillary electrophoresis electrospray mass spectrometry. Analytical Biochemistry. 311(1). 80–83. 10 indexed citations
10.
Trevillyan, James M., X. Grace Chiou, Stephen J. Ballaron, et al.. (1999). Inhibition of p56lckTyrosine Kinase by Isothiazolones. Archives of Biochemistry and Biophysics. 364(1). 19–29. 28 indexed citations
11.
Kati, Warren M., Hing L. Sham, Jennifer McCall, et al.. (1999). Inhibition of 3C Protease from Human Rhinovirus Strain 1B by Peptidyl Bromomethylketonehydrazides. Archives of Biochemistry and Biophysics. 362(2). 363–375. 17 indexed citations
12.
Stassi, Diane L., Kevin A. Reynolds, Geewananda P. Gunawardana, et al.. (1998). Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. Proceedings of the National Academy of Sciences. 95(13). 7305–7309. 102 indexed citations
13.
Buko, Alex, et al.. (1995). Fusacandins A and B; Novel Antifungal Antibiotics of the Papulacandin Class from Fusarium sambucinum. II. Isolation and Structural Elucidation.. The Journal of Antibiotics. 48(7). 614–618. 16 indexed citations
15.
Buko, Alex, et al.. (1994). Altromycins E, F, G, H and I; additional novel components of the altromycin complex.. The Journal of Antibiotics. 47(10). 1160–1164. 11 indexed citations
16.
Hochlowski, Jill E., et al.. (1991). Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. II. Isolation and elucidation of structures.. The Journal of Antibiotics. 44(12). 1318–1330. 21 indexed citations
17.
McAlpine, James B., et al.. (1990). Altromycins, novel pluramycin-like antibiotics. II. Isolation and elucidation of structure.. The Journal of Antibiotics. 43(3). 229–237. 28 indexed citations
18.
Hochlowski, Jill E., et al.. (1988). Phenelfamycins, a novel complex of elfamycin-type antibiotics. II. Isolation and structure determination.. The Journal of Antibiotics. 41(10). 1300–1315. 23 indexed citations
19.
Rasmussen, Ronald R., et al.. (1987). Coloradocin, an antibiotic from a new Actinoplanes. II. Identity with luminamicin and elucidation of structure.. The Journal of Antibiotics. 40(10). 1383–1393. 23 indexed citations
20.
McAlpine, James B., et al.. (1987). New antibiotics from genetically engineered actinomycetes. I. 2-norerythromycins, isolation and structural determinations.. The Journal of Antibiotics. 40(8). 1115–1122. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026